SCHEMBL26318137

SCHEMBL26318137

C=Cc1ccc(C[Si](C)(C)CCl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
MAPT P10636 4/20 0.36
TP53 P04637 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.34
HDAC8 Q9BY41 2/20 0.34
F2R P25116 1/20 0.33
ESR1 P03372 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
LMNA P02545 2/20 0.30
PSMD14 O00487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28846222 0.90 ALDH1A1 (0.50) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL9715846 0.82 ALDH1A1 (0.46) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL619307 0.82 ALDH1A1 (0.46) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL28846186 0.82 ALDH1A1 (0.46) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL8760301 0.81 ESR1 (0.52) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL18135553 0.78 ALDH1A1 (0.38) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL10523793 0.78 ALDH1A1 (0.46) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL15807759 0.78 ALDH1A1 (0.46) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL9509524 0.78 ALDH1A1 (0.46) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL10626255 0.78 ALDH1A1 (0.46) ALDH1A1MAPTTP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295189-A1 Organozinc Compound Preparation Method, Chain Transfer Agent, Block Copolymer, and Resin Composition LG CHEM, LTD. (KR) 2023-09-21 US disclosed
US-20230295189-A1 Organozinc Compound Preparation Method, Chain Transfer Agent, Block Copolymer, and Resin Composition LG CHEM, LTD. (KR) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295189-A1 Organozinc Compound Preparation Method, Chain Transfer Agent, Block Copolymer, and Resin Composition RTCB, ZKSCAN2, ZCCHC8 ALDH1A1 3150/4885MAPT 1072/4885TP53 2913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.